About: Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Leonard-Meron Biosciences, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $0.56 (+1.79%)
CTOR NASDAQ Citius Oncology, Inc.
Citius Oncology, Inc. share price
CTOR price activity
Last Price
$0.560
Change (24hr)
0.02 USD (3.01%)
Volume
96.68K
Volume (4w avg)
-
Open
$0.55
Day Range
$0.54 - $0.58
Previous Close
$0.55
Last Trade
18 Nov, 5:19 pm GMT+0
Delayed
18 Nov, 5:19 pm GMT+0
CTOR price performance
Delayed
18 Nov, 5:19 pm GMT+0
CTOR details
CTOR Market Signals